
    
      A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Ⅱ Optimal Dose-finding
      Study to Evaluate the Safety and Efficacy of Botulax® in Subjects with Benign Masseteric
      Hypertrophy
    
  